WallStSmart

VNET Group Inc DRC (VNET)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

VNET Group Inc DRC generates 3743% more annual revenue ($9.95B vs $258.90M). VNET leads profitability with a -2.5% profit margin vs -15.5%. VNET earns a higher WallStSmart Score of 59/100 (C).

VNET

Buy

59

out of 100

Grade: C

Growth: 8.7Profit: 3.5Value: 8.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VNETUndervalued (+79.1%)

Margin of Safety

+79.1%

Fair Value

$64.79

Current Price

$8.30

$56.49 discount

UndervaluedFair: $64.79Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VNET4 strengths · Avg: 9.0/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

EPS GrowthGrowth
133.3%10/10

Earnings expanding 133.3% YoY

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
19.6%8/10

19.6% revenue growth

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

VNET3 concerns · Avg: 1.7/10
Return on EquityProfitability
-1.7%2/10

ROE of -1.7% — below average capital efficiency

Free Cash FlowQuality
$-3.01B2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-2.5%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : VNET

The strongest argument for VNET centers on PEG Ratio, EPS Growth, Price/Book. Revenue growth of 19.6% demonstrates continued momentum. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : VNET

The primary concerns for VNET are Return on Equity, Free Cash Flow, Profit Margin.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

VNET profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VNET scores higher overall (59/100 vs 41/100) and 19.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

VNET Group Inc DRC

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · China

21Vianet Group, Inc., an investment holding company, provides hosting and related services to Internet companies, government entities, blue-chip companies, and small and medium-sized enterprises in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?